{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:20:39Z","timestamp":1788808839622,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jpeds.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T07:53:03Z","timestamp":1436082783000},"page":"645-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis"],"prefix":"10.1016","volume":"167","author":[{"given":"Rosa","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady S.","family":"Moffett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaina","family":"Karabinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3721-614X","authenticated-orcid":false,"given":"Danielle","family":"Guffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Donald H.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2015.06.006_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/hq0701.093686","article-title":"Mechanism of action and pharmacology of unfractionated heparin","volume":"21","author":"Hirsh","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpeds.2015.06.006_bib2","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jpeds.2015.06.006_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0003-4975(00)01550-2","article-title":"A randomized trial of antithrombin concentrate for treatment of heparin resistance","volume":"70","author":"Williams","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jpeds.2015.06.006_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1067\/mtc.2002.119060","article-title":"Antithrombin concentrate to treat heparin resistance in patients undergoing cardiac surgery","volume":"123","author":"Lemmer","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jpeds.2015.06.006_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtcvs.2004.10.045","article-title":"Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass","volume":"130","author":"Avidan","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jpeds.2015.06.006_bib6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/hrt.2003.024299","article-title":"Anticoagulation in the young","volume":"90","author":"Monagle","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jpeds.2015.06.006_bib7","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","article-title":"Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association","volume":"128","author":"Giglia","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2015.06.006_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jpeds.2013.06.036","article-title":"Antithrombin concentrate use in children: a multicenter cohort study","volume":"163","author":"Wong","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.06.006_bib9","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/j.1538-7836.2011.04433.x","article-title":"Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children","volume":"9","author":"Mitchell","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpeds.2015.06.006_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1440-1754.2012.02451.x","article-title":"A clinical audit of antithrombin concentrate use in a tertiary pediatric center","volume":"48","author":"Kozul","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2015.06.006_bib11","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1097\/PCC.0000000000000174","article-title":"Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study","volume":"15","author":"Ryerson","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jpeds.2015.06.006_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MAT.0000000000000099","article-title":"Administration of antithrombin concentrate in infants and children on extracorporeal life support improves anticoagulation efficacy","volume":"60","author":"Ryerson","year":"2014","journal-title":"ASAIO J"},{"key":"10.1016\/j.jpeds.2015.06.006_bib13","unstructured":"Thrombate (human antithrombin III) [package insert]. North Carolina, USA; Grifols Therapeutics Inc.: Published August 2013. http:\/\/www.talecris-pi.info\/inserts\/thrombate.pdf. Accessed January 12, 2015."},{"issue":"4","key":"10.1016\/j.jpeds.2015.06.006_bib14","first-page":"CD005383","article-title":"Antithrombin for respiratory distress syndrome in preterm infants","author":"Bassler","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2015.06.006_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-2007-991533","article-title":"Antiangiogenic antithrombin","volume":"33","author":"O\u2019Reilly","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jpeds.2015.06.006_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1203\/00006450-199401000-00016","article-title":"Heparin therapy in pediatric patients: a prospective cohort study","volume":"35","author":"Andrew","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2015.06.006_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3324\/haematol.10616","article-title":"A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study","volume":"92","author":"Kuhle","year":"2007","journal-title":"Hematologica"},{"key":"10.1016\/j.jpeds.2015.06.006_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1538-7836.2012.04624.x","article-title":"Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels","volume":"10","author":"Schechter","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpeds.2015.06.006_bib19","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1016\/0002-9343(89)80533-9","article-title":"Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin","volume":"87","author":"Schwartz","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jpeds.2015.06.006_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2362.1977.tb01566.x","article-title":"Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration","volume":"7","author":"Collen","year":"1977","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jpeds.2015.06.006_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0049-3848(91)90272-X","article-title":"Heparin sensitivity and resistance in the neonate: an explanation","volume":"63","author":"Vieira","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.jpeds.2015.06.006_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-2007-1002752","article-title":"The use of heparin in newborn infants","volume":"14","author":"Andrew","year":"1988","journal-title":"Semin Thromb Hemost"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615005892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615005892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T13:38:13Z","timestamp":1562593093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347615005892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0022347615005892"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.06.006","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}